Search Results 291-300 of 19731 for CLL
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
Research. Mayo Clinic doctors and scientists are actively studying new ways of treating chronic lymphocytic leukemia. Blood cell and bone marrow cancer research ...
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...
-
... chronic lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. DNA Methylation in Adenocarcinoma of the Prostate ...
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...
-
Chronic lymphocytic leukemia (CLL); Waldenstroms macroglobulinemia; Experimental therapeutics; Drug resistance in multiple myeloma; Novel therapeutics in ...
-
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
-
This episode of "Tomorrow's Cure" explores how a type of blood cancer, chronic lymphocytic leukemia (CLL), is hard to detect early in its development and ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
... CLL to patients with untreated intermediate and high-risk CLL. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...